The Institute of Marine and Environmental Technology has opened its new incubator, called Harbor Launch. The incubator is designed for biotech and environmental science startups, and is looking for its first member companies. The Inner Harbor space can accommodate between 10 and 15 companies and has access to four small wet labs — a crucial resource for the kind of startups IMET wants to attract.
A Center for Regional Economic Competitiveness (CREC) team, including staff and senior fellows, recently concluded a review of state financing and incentive programs for the Maryland Economic Development Commission and the Maryland Department of Commerce. Thanks to guest blogger Catherine Renault for this project summary.
Johns Hopkins Medicine has recently received approval to perform organ transplants between HIV-positive donors and recipients.
The hospital announced in a news release Monday that it plans to perform the nation’s first kidney transplant between an HIV-positive donor and recipient and the first such liver transplant in the world. These transplants could take place as soon as a suitable organ becomes available and a recipient is identified and prepared.
The University Science Center, a research park in Philadelphia, has announced the six startups that will be part of the second class for its health tech accelerator, called Digital Health Accelerator.
The program will run for a year, which is significantly longer than its last program, a 10-week class. When the accelerator is finished, startups receive up to $50,000. The Center adds that startups in the program will also get to network with insurance companies, pharmaceutical companies, hospitals, and research institutions. Startups also receive coworking office space during the program.
APPLICATIONS FOR SPRING 2016 DUE March 1, 2016
At Illumina, we’re committed to unlocking the power of the genome, but we know we can’t do it alone. The Illumina Accelerator is our way of accelerating innovation in the entrepreneurial community. With extensive mentorship, financial support, and access to sequencing systems, reagents, and lab space, we’ve created a dynamic genomic ecosystem to help startups launch. Together we’ll advance the solutions that will transform medicine and improve human health.
Michael Milken, one of the biggest medical philanthropists in the country, on medical research today.
Before the winter edition of HopHacks kicked off, a big crowd turned out at Johns Hopkins to hear about nurturing startups at scale from a pair of Y Combinator staffers.
The big takeaway of this YC Winter Tour for startups is pretty straightforward: applications for the biannual seed accelerator program are open. The Mountain View, Calif.-based accelerator program runs two batches each year. It provides $120,000 to each startup in exchange for 7 percent equity.
For the past five years until January, a team of federal contractors has been poring over academic journals, news reports and press releases in search of emerging technology that could change the outcome of clinical care.
The team’s goal was to write reports containing lists of topics worth further research from the Department of Health and Human Services. The assessment team surfaced medical products and techniques such as “wearable artificial kidney for managing end-stage renal disease” or “joint-sparing knee implant[s] for treatment of knee osteoarthritis,” according to the team’s report from last year.
In the blink of an eye, a business world that required only antivirus protection now requires far better solutions to combat sophisticated, determined ‘bad actors’ who want to steal your valuable information. You can’t pick up a newspaper or watch a news program and not read or hear about an important breach. Despite spending at a rate of $100 billion annually, global damages from cybersecurity breaches and attacks are on a trajectory to increase from $500 billion to potentially more than $2 trillion per year.
US President Barack Obama’s plan to get a vast Pacific Rim trade deal through Congress this year is taking flak from the presidential campaign trail, where disdain for the pact appears to be one of the rare unifying themes for almost everyone from Donald Trump to Hillary Clinton.
